Regulatory Actions
GSK announces nationwide availability of once-a-day Coreg CR for the treatment of three key cardiovascular conditions
Published in Medical Letter on the CDC and FDA, April 8th, 2007
High blood pressure, also known as hypertension.
A heart attack that has reduced how well the heart pumps (known medically as post-myocardial infarction left ventricular dysfunction).
Mild to severe heart failure.
The availability of once-a-day COREG CR eases the pill burden for patients who previously had to take Coreg(R) (carvedilol) twice-a-day. COREG CR is bioequivalent to the original...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Epidemic
Researchers Find Surprising Pattern of Influenza Spread in South America and Tropics - Malaria
Collaborative effort to investigate new treatment for severe ,alaria - Plague
Will the plague pathogen become resistant to antibiotics? - Regulatory Actions
FDA Proposes New, Tougher Procedures for Membership on Advisory Committees - Society for Women’s Health Research
Statement from SWHR on FDA Office of Women’s Health Funding - Ulcerative Colitis
Lialda -- the first oral once-daily mesalamine for ulcerative colitis -- now available - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
